This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/about/ebr-terms.html Results: Nine RCTs were included in the systematic review and four were found to be eligible for inclusion in a meta-analysis. Participants in the SM group had improved symptoms compared with participants receiving sham treatment (SMD=-0.36; 95% CI -0.59,-0.12). The majority of studies were of low risk of bias, however several of the studies were small, the practitioner could not be blinded, some studies did not conduct intention-to-treat (ITT) analysis and had a high level of drop outs. Conclusions: Thus given the small number of studies included in this analysis, we should be cautious of making strong inferences based on these results.
INTRODUCTION
Over the course of a lifetime approximately 80% of people will experience low back pain (LBP). Non-specific low back pain (NSLBP) is the second most common reason for worker absenteeism 1, 2 and is the most common reason to attend a manual therapy clinic. 3, 4 NSLBP is characterised by pain in the posterior lumbar spine, sacral spine or paraspinal tissues which may be accompanied by decreased range of motion. 5 The aetiology is unclear and a definitive cause remains elusive for researchers. 6 Several different approaches to treatment have been identified, with mixed evidence for their success. 7, 8, 9 One of the treatments widely used is spinal manipulation (SM).
Spinal Manipulation and Mobilisation
SM can be defined as "treatments that use high velocity/low amplitude (HVLA) to move a joint that is exhibiting somatic dysfunction through its restrictive barrier." Several models suggest that this technique would be able to produce a hypo-analgesic effect, either by structural 11, 12, 13 or neurological processes, 14, 15 whilst others have postulated it acts through non-specific or 'placebo' effects. 16, 17 In contrast, spinal mobilisation uses low velocity/low amplitude cyclical techniques (non-thrust mobilisation); it has been argued that this method of action differs from that of HVLA techniques, thus mobilisation and manipulation should be investigated separately. 18 SM can have serious (although very rare) adverse outcomes such as intervertebral disc prolapse and fracture, 19 whereas there are no reported adverse events reported from receiving non-thrust spinal mobilisation. 5 If it could be established that there were no specific treatment benefits from HVLA techniques on NSLBP then it would be inappropriate to perform them on patients.
Controlling the Placebo Effect in Trials of SM
In order to exclude possible placebo effects in trials of SM, the control group must either be screened for previous experience of SM, 20 or be exposed to an effective sham intervention.
There is little agreement among experts as to what constitutes an effective sham manipulation. 21 However, there is some evidence as to what may be acceptable as an 23 showed participants videos of side-lying SM, light touch or ultrasound to gauge patients' perceptions of treatments for lumbar spine pain. The participants viewed SM as the therapy most likely to reduce pain and improve function, suggesting that a sham needs to physically resemble a SM technique for it to be believable. Hawk and Long (2000) 24 and Machado et al (2008) 25 also identified the importance of equalization of the non-specific effect of physical touch between participants. The use of an indistinguishable placebo should counteract any subtle differences between groups shown to influence treatment outcomes. 26, 27 Other active therapies are not considered a viable control as they can lead to erroneous interpretation due to varied contextual factors which produce a placebo effect or specific treatment effects. 28 Thus, for a sham manipulation to be an effective control it should physically resemble a HVLA technique and be performed so as to eliminate subtle differences between the intervention group and the control group. For the purpose of this review the term "effective" sham control is used to denote control groups that met these criteria. However, no meta-analysis was performed.
Fulda et al (2007)
This systematic review critically evaluates data from randomised controlled trials (RCTs) using HVLA techniques for people with NSLBP. The aim is to assess SM in isolation rather than as part of a treatment package of care. Any specific treatment effects or adverse events that are identified can be isolated to SM. To be eligible, the comparison group had to be an effective sham.
METHODS
The following databases were searched from their inception to articles and all relevant systematic reviews were hand-searched for additional studies.
A protocol was produced and can be found at http://www.crd.york.ac.uk/PROSPERO/, reg number CRD42014008886.
Study selection
All titles and abstracts retrieved from the searches were assessed for eligibility.
Articles that appeared to meet the inclusion criteria were retrieved in full and independently considered for inclusion by two reviewers (JR, RP). Disagreements were resolved through discussion (see Fig 1 for Only completed RCTs were included (reports of ongoing trials were excluded (e.g.
protocol papers)). The primary outcome was any measure of pain (both standardised and non-standardised). The secondary outcome was any adverse event mentioned.
Data from included studies were extracted independently by two reviewers (JR, RP) using a form with pre-defined criteria. The manuscript was developed using the Preferred Reporting Items for Systematic
Reviews and Meta-analysis (PRISMA) checklist.
Meta-analysis
Meta-analyses were performed in Stata 13 (Stata, College Station, TX), using the usercontributed commands metan 38 and metafunnel. 39 Standardised mean differences (SMD) and corresponding standard errors were calculated for included studies using means, standard deviations and sample sizes reported in the relevant publications.
Due to the small sample sizes of some studies, Hedges' g, an extension of Cohen's d adjusted for small sample bias, was calculated. 40 A negative SMD corresponds to a lower pain score being associated with the SM group.
Effect estimates were pooled using a random effects model. Unlike a fixed effects model, which assumes that each study estimates the same effect size, a random effects model assumes that each study estimates a different effect, but that these are drawn from some common distribution. 41 Thus, in addition to random sampling error, differences may also be due to dissimilarities between study populations and designs.
The I 2 statistic was also calculated, which measures inconsistency between estimates and is independent of sample size. 42 
Post-hoc Sensitivity analysis
Initially, only studies reporting results at follow up were included in the main analysis, using the last follow up time point as comparison. However to maximise comparability, the 1 month follow up data from Senna et al's (2011) 43 study was used in this analysis (as opposed to the last time point at 10 months). One sensitivity analysis included only studies which collected pain measurements immediately post-treatment. A further sensitivity analysis investigated the effect of including studies assessed as being at a high risk of bias. 33 
Dealing with missing data
Where possible, we extracted the number of participants randomised to a treatment arm, the mean pain score, and standard deviation for each group. In some cases, only means and standard errors were reported, in which case the group sizes were used to estimate the corresponding standard deviation. 43 In one case, we were unable to extract relevant information from the initial publication, but instead results reported in a subsequent review which included this study. 33 Where there was insufficient information we contacted authors.
RESULTS
The literature search identified 1625 potentially relevant titles and abstracts. After screening, nine RCTs were identified that met the inclusion criteria for this review. The studies were published from 1986 to 2014. Five originated from USA, 33, 44, 45, 46, 89 one from Canada, 47 one from France, 48 one from Egypt 43 and one from Germany. 49 Eight were in English and one in French. 48 The total number of participants enrolled was 646
(252 male, 394 female), the sample size varied from 6 to 145 and age ranged from 18-65 years. The mean age of participants was incalculable due to incomplete reporting in one of the trials. 44 Four types of pain outcome measure were used. To assess pain levels directly either a Visual Analogue Scale (VAS) or Numerical Rating scale (NRS)
were used. To assess physical function due to pain either the Oswestry Low Back Pain Disability Questionnaire (OLBPDQ) or the Roland-Morris Low Back Pain Questionnaire (RMLBPQ) were used. A summary of the main characteristics is presented in Table 1 and Risk of Bias assessment is presented in Table 2 .
The number of treatments given varied between studies (1 to 12), although two studies 33, 44 did not report the total number. The two most common methods of SM were side lying, long lever rotational thrust or a supine thrust to the anterior pelvis with the participant rotated away from the lesion. Two studies adjusted anywhere along the spine. 33, 45 None of the studies specified which joints were being targeted. Follow up times varied from no follow up to 10 months, with the majority adopting a two week follow-up.
Risk of Bias
Overall, only one study was assessed as having a high risk of bias. 33 The remaining eight studies were rated as low risk of bias as they achieved a score greater than 6 (see table 2 ). For sequence generation, six 43, 45, 46, 48, 49, 80 of the nine trials were assessed as having low risk of bias, the risk of bias for the remaining three were unclear. For allocation concealment three were rated as low; 46, 49, 89 the majority were again unclear.
With regards to blinding of participants, the majority of studies were assessed as low risk of bias due to the nature and quality of the sham procedure. Participants also acted as outcome assessors when using self-rating scales thus effective blinding of outcome assessor was possible. One study 45 assessed effectiveness of blinding postintervention and found a higher number correctly guessed group assignment in the SM group. Bialosky et al (2014) 46 assessed believability of the placebo intervention and found that those receiving the placebo were more likely to believe their intervention was a sham than those in the SM or enhanced placebo group (63% V 33% P<0.05). 47 had anesthetised all participants, so blinding was complete here. Blinding of the practitioner was impossible in all trials as they would be aware which type of manipulation they were performing.
Kawchuk et al (2009)
The remaining criteria (selective outcome reporting, intention to treat analysis, cointerventions reported, compliance levels assessed) were all rated as low risk of bias.
Results from the pain outcome measures
Six studies 33, 43, 45, 48, 49, 89 used a 100 mm VAS pain measure. Five reported an improvement in outcome, with SM groups showing lower levels of pain post-treatment and at follow up. One study 46 also used an 11 point numerical pain rating scale but no difference was found between groups.
Four studies 43, 45, 46, 89 used the OLBPDQ to measure physical function due to pain levels.
Two studies 43, 45 reported an improved outcome with SM.
Senna et al (2011) 43 found differences between non-maintained SM and sham group at 1 and 4 months using the VAS but the mean pain score gradually returned to pretreatment levels after the treatment was stopped (1 month). They also found evidence of a difference (p=0.005) using the OLBPDQ at 1 month follow up but no other time points. In contrast, the maintained SM group continued improving, indicating SM needs to be maintained to have a lasting effect.
Von Heymann et al (2013) 49 compared groups receiving SM (plus placebo medication) with a sham (plus placebo medication). However, no formal comparison was made between these arms. An interim analysis found the active treatments to be superior, after which the sham arm was dropped and the trial continued as a 2-arm study comparing only the two active treatments (SM versus a non-steroidal anti-inflammatory drug "diclofenac").
Waagen et al (1986) 33 found improvements in pain measured using the VAS in both the experimental group and the control group immediately after the intervention. At the two week post-treatment assessment there was evidence of reduced pain in the experimental group only.
One study 47 of just six participants, used an 11-point scale to measure pain. The authors report a greater proportion of the SM group experiencing less pain, however they do not report any formal analysis.
Triano et al (1995) 89 found evidence of a difference in functioning levels due to pain (OLBPDQ) between the three treatment arms at immediately post-treatment (p=0.012),
with SM reporting the lowest scores. There was no difference between groups at the two week follow up. The VAS showed a similar pattern of results, although there was no longer evidence of an effect at two weeks. 45 reported a decrease in pain and disability scores using the VAS and the OLBPDQ from baseline to 2 week follow up in all treatment arms. The SM group showing the greatest decline in scores. They found weak evidence of a difference between the change for each group (P= 0.087) using the OLBPDQ. Hadler et al (1987) 44 used the RMLBPQ to assess outcomes and reported evidence of an effect of SM among participants who had suffered with NSLBP between 2-4 weeks at the 3 day follow up but not at any other time point.
Hoiiris et al (2004)
Drop outs were described and acceptable (<10%) in five studies. Four studies had high dropout rates (>10%) 33, 43, 49, 89 three of which indicated the control group had the largest dropout rate.
33,43,49

Adverse events
Only three trials reported on adverse events. Senna et al (2011) 43 reported that the most common adverse events were local discomfort and tiredness, which had resolved within 24 hours. The other two papers just stated that none were reported. 47, 49 The effect of the intervention
The effect of SM for NSLBP as measured by the 100mm VAS is presented in the summary of findings table (table 3) . From four studies 43, 45, 48, 89 (287 participants) the SMD is -0.36 (95%CI: -0.59,-0.12).The quality of evidence is graded as low due to high drop out in two studies, 43, 89 broken blinding in one study, 45 no practitioner could be blinded in any study and only one 48 study conducted intention-to-treat (ITT) analysis.
Meta-analysis
Of the nine included studies, five 33, 43, 45, 48, 89 reported results of the VAS sufficiently for inclusion in a meta-analysis, with four included in the main meta-analysis and five included in either of the two sensitivity analyses.
Each of the following studies recorded information at either two week 45, 89 or one month follow up. 43, 48 These four studies were the only ones with sufficient information for inclusion in the main meta-analysis. After combining effect estimates using a random effects model, we found a pooled SMD of -0.36 (95% CI: -0.59,-0.12), corresponding to a reduction in pain among participants in the SM group at follow up. The I 2 statistic suggests no strong evidence against the assumption of homogeneity between effect estimates (I 2 <0.1%, p=0.835). However, given that there are only four studies included in this analysis, caution should be taken making inferences based on these analyses (see Fig 2) .
Three studies 45, 48, 89 reported information collected immediately post-treatment and this was analysed in a sensitivity analysis (Fig A1) . Waagan et al (1986) 33 was excluded from the main meta-analysis due to having high risk of bias score (see table 4 ), but included in a sensitivity analysis (Fig A3) . Given the small number of studies included in this analysis, it is difficult to infer too much from the funnel plot, although there is no clear indication of small study effects (see Fig A5 in appendix) .
Sensitivity analyses
The analysis run using the post-treatment pain scores show a similar pattern to the follow up scores, with a consistent direction of effect and an attenuated estimate (SMD = -0.35, 95% CI: -0.61, -0.08) (see Fig A1) .
Analysis run including Waagen et al. (1986) , 33 assessed to be high risk of bias, found results consistent with the main analysis (SMD = -0.37, 95% CI: -0.60, -0.14) (see Fig.   A3 ).
Forest and funnel plots for the sensitivity analyses can be found in Appendix 4 (Figs A1-A5).
DISCUSSION
The objective of the present review was to systematically identify and critically evaluate the evidence from RCTs of spinal manipulation compared to an effective sham placebo on NSLBP. This is the first review to compare SM to an effective control. The review included nine studies of which four were included in the meta-analysis. The majority of trials used either a 100 mm VAS to assess pain levels or the OLBPDQ/RMLBPDQ to assess physical function due to NSLBP. 45 used an additional placebo medicine in both groups which may have lessened any relative difference.
Only four studies 44, 45, 46, 49 attempted to standardise the interaction between patient and practitioner to reduce any placebo effect by way of contextual factors. 26 ,27,52,53 All other studies did not control for these variables, weakening their findings. There was much variation in number of treatments given and timing of outcome assessments between studies, making application to practice more difficult to establish. The majority of studies either had no follow up or just two weeks post intervention; a longer follow up would be required to ascertain long-term effectiveness of the intervention.
Limitations of the Review
Although the search strategy was comprehensive it is possible that some published clinical trials may not have been identified. However, our systematic and detailed search strategy make this unlikely, it is more likely that we did not identify eligible unpublished trials. Publication bias is a problem in all medical research 54 and it is a particular problem in alternative medicine. 55, 56 Furlan et al (2009) 36 recommend studying NSLBP in groups determined by the duration of symptoms as there are differences in the clinical course depending on the length of time symptoms have been present. However, this was not possible in this review given the limited number of trials that met the inclusion criteria.
Deviations from the protocol
We conducted two post-hoc sensitivity analyses which were not planned or originally stated in the protocol but were deemed important once data was extracted. One was to include studies of high risk of bias 33 and the other was to see if there was a difference at immediately post-intervention compared to last follow up (using one month data rather than the 10 month follow up data for consistency 43 ). There was very little variation in the findings. Functional outcomes (RMLBPDQ and OLBPDQ) due to pain levels were also extracted as it was deemed further indication of pain levels.
Adverse Events
Poor reporting of adverse events is a frequent criticism of complementary and alternative medicine (CAM) research. 57 Several previous reviews on complications of SM emphasise its safety, 58, 59 however serious adverse events have been reported. 19 In this review few studies reported on adverse events at all. In one study, 47 the potential for adverse events to occur was higher as they used anaesthetic to ensure adequate blinding of participants; this procedure may be considered an unnecessary risk.
Recommendations for Future Research
Manual therapy practitioners are under pressure to produce evidence for their interventions. 16 
Application to Practice
Several reviews have concluded suggesting that SM is no more or less effective than other treatments with proven benefits for NSLBP. 30, 66 SM may carry a greater risk of adverse events, unlike non-thrust mobilisation 5 and massage. 51 Our review, however, found evidence for an effect of SM over effective control. There is currently insufficient evidence to inform practice. The decision to receive SM needs to be made by the patient who should be made aware of the current uncertainty.
Conclusions
There is some evidence from four of the nine trials (287 participants) that SM has specific treatment effects and is more effective at reducing NSLBP when compared to an effective sham intervention. Although the effect was small-medium in terms of clinical relevance, a similar effect was found both immediately post-treatment and at follow up. Inconsistency of results across all studies may be due to the use of different interventions, controls, outcome measures and variable standards of methodology between studies. Currently, the evidence is insufficient to inform practice. Further adequately powered, well designed studies are required.
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XXXXXXXXXXXX is a registered osteopath who uses spinal manipulation in the treatment of patients. Pps between 18-60 yrs, suffering NSLBP ≥ 4/10 over 24hrs on NRS Supine, side bent towards and rotated away from the lesion, a thrust forces applied to the anterior pelvis in a posterior and inferior direction. No levels specified
Sham -Supine, no side bending, patient rotated away from the lesion then returned pre thrust, the thrust was delivered into the table.
Enhanced sham-same physical procedure + suggestion to patient of the benefits of the sham procedure. * Outcome assessor is participant when rating self-report scales like the VAS, RMLBPDQ (Roland Morris Low Back Pain Disability Questionnaire), OLBPDQ (Oswestry Low back pain disability Questionnaire) ** <10%; YES =1, NO = 0, ? = unclear a = although authors claim the chiropractor was blinded -this would be impossible; b = between the Intervention and sham; c= both also received placebo medicine; d = differences in number of treatments over differing duration periods; e= soft tissue performed in sham group only; f = no dropouts; g= no mention of analysis; h= some analysis of height and weight; i= blinding of participant was tested and perception of true chiropractic care was sig. higher in chiropractic group (P<0.05); j = the authors did not report compliance directly so we have inferred compliance from people completing the treatment programme; k = based on medication logs or kits respectively. Small to moderate SMD = -0.36 (95% CI: -0.59, -0.12) CI = Confidence Interval GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate Very low quality: We are very uncertain about the estimate 1 Judgements of low risk of bias (>6) in all studies included in the main meta-analysis, however high level of dropouts in 2 studies, no ITT analysis in 3 studies, all practitioners could not be blinded 2 The sham manipulation ensured blinding of participants, although one 45 tested blinding and it is possible it may have been broken Total score = no of yes answers /12
The risk of bias for RCTs was assessed using the criteria list recommended in the Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group.
Scores of 6 or more were considered low risk of bias Learman et al 2009 80 Although the subjects were extensively screened for pain levels at entry to the study, no follow up data measuring pain was assessed.
Licciardone et al 2003 32 Several different and non-standardised interventions (muscle energy techniques, soft tissue manipulation, fascial manipulation and cranio-sacral) were made both in the treatment group, the sham group received 'fake' treatments in the same modalities.
Licciardone et al 2013 81 Several different and non-standardised interventions (muscle energy techniques, soft tissue manipulation, fascial manipulation and cranio-sacral) were made both in the treatment group, the sham group received 'fake' treatments in the same modalities.
Ongley et al 1987 82 As well as a spinal manipulation, painkilling injections were being administered, in the control group the amount of painkilling injection was lowered therefore influencing reported pain levels Mandara et al 2008 83 No full data available, abstract is published as a conference presentation, repeated attempts were made to contact the authors with no response. 
